Cited by 166Asthma and respiratory diseasesIL-33, ST2, and ILC PathwaysAllergic Rhinitis and Sensitization

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.

IL-13 and IL-4 cause eotaxin release in human airway smooth muscle cells: a role for ERK

Moore, Paul E., Church, Trudi L., Chism, David D., Panettieri, Reynold A., Shore, Stephanie A.·2002·American Journal of Physiology-Lung Cellular and Molecular Physiology

DOI 10.1152/ajplung.00245.2001

Open this paper in CoChat — free account

Abstract

Human airway smooth muscle (HASM) cells express interleukin (IL)-13 and IL-4 receptors and respond to these cytokines with signal transducer and activator of transcription-6 and extracellular signal-regulated kinase (ERK) activation. The purpose of this study was to determine whether IL-13 and/or IL-4 influence eotaxin release in HASM cells and whether the ERK mitogen-activated protein (MAP) kinase pathway is involved in these events. Eotaxin release into HASM cell supernatants was assayed by ELISA, and eotaxin mRNA expression was determined by Northern blot analysis. Pretreatment with either IL-13 or IL-4 resulted in a concentration- and time-dependent release of eotaxin, although IL-4 was more effective. Eotaxin release was approximately twice baseline after treatment with 50 ng/ml IL-13 or IL-4 ( P < 0.001). IL-13 and IL-4 also acted synergistically with tumor necrosis factor (TNF)-α to induce eotaxin release: TNF-α alone (10 ng/ml for 24 h) resulted in an approximately fourfold increase in eotaxin release, whereas TNF-α in combination with IL-13 or IL-4 resulted in 10- or 20-fold increases ( P < 0.05). Similar results were obtained for eotaxin mRNA expression. Pretreatment with either U-0126 (10 μM) or PD-98059 (30 μM), both inhibitors of MAP/ERK kinase, the enzyme upstream of ERK, inhibited IL-13- or IL-4-induced eotaxin release ( P < 0.05). U-0126 also inhibited IL-13, and TNF-α induced mRNA expression. Our results indicate that IL-13 and IL-4 cause eotaxin release in HASM cells through a mechanism that, in part, involves ERK activation and suggest that the smooth muscle may be an important source of chemokines leading to eosinophil recruitment in asthma.

Integrity signals

Registry

Crossref · 10.1152/ajplung.00245.2001

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

PD 098059 Is a Specific Inhibitor of the Activation of Mitogen-activated Protein Kinase Kinase in Vitro and in Vivo
Alessi, D. R., Cuenda, A., Cohen, P., Dudley, D. T., & Saltiel, A. R. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.46.27489 · Cited by 3,374
Identification of a Novel Inhibitor of Mitogen-activated Protein Kinase Kinase
Favata, M. F., Horiuchi, K. Y., Manos, E. J., Daulerio, A. J., Stradley, D. A., Feeser, W. S., Dyk, D. E. V., Pitts, W. J., Earl, R. A., Hobbs, F. W., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.29.18623 · Cited by 3,016
A synthetic inhibitor of the mitogen-activated protein kinase cascade.
Dudley, D. T., Pang, L., Decker, S. J., Bridges, A. J., & Saltiel, A. R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.17.7686 · Cited by 2,679
Requirement for IL-13 Independently of IL-4 in Experimental Asthma
Grünig, G., Warnock, M. L., Wakil, A. E., Venkayya, R., Brombacher, F., Rennick, D. M., Sheppard, D., Mohrs, M., Donaldson, D. D., Locksley, R. M., et al. (1998) · Science · doi:10.1126/science.282.5397.2261 · Cited by 1,845
Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production
Zhu, Z., Homer, R., Wang, Z., Chen, Q., Geba, G. P., Wang, J., Zhang, Y., & Elias, J. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5909 · Cited by 1,730
Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation.
Jose, P. J., Griffiths-Johnson, D. A., COLLINS, P. D., Walsh, D. T., Moqbel, R., Totty, N. F., Truong, O., Hsuan, J. J., & Williams, T. J. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.3.881 · Cited by 806
Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia
García-Zepeda, E. A., Rothenberg, M. E., Ownbey, R. T., Celestin, J., Leder, P., & Luster, A. D. (1996) · Nature Medicine · doi:10.1038/nm0496-449 · Cited by 683
Phosphorylation at threonine-235 by a ras-dependent mitogen-activated protein kinase cascade is essential for transcription factor NF-IL6.
Nakajima, T., Kinoshita, S. M., Sasagawa, T., Sasaki, K., Naruto, M., Kishimoto, T., & Akira, S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.6.2207 · Cited by 573
Inflammation of small airways in asthma☆☆☆★★★
Hamid, Q. A., Song, Y., Kotsimbos, T. C., Minshall, E., Bai, T. R., Hegele, R. G., & Hogg, J. C. (1997) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(97)70193-3 · Cited by 548
Targeted Disruption of the Chemokine Eotaxin Partially Reduces Antigen-induced Tissue Eosinophilia
Rothenberg, M. E., MacLean, J. A., Pearlman, E. M., Luster, A. D., & Leder, P. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.4.785 · Cited by 524

Flagged first, then by citations

Show all 49 references

Research works printed but not linked: 4

Bamford TL, 2000, Am J Respir Crit Care Med, 161, A599
Feng N, 1998, Lab Invest, 78, 591
Gingras S, 2000, Mol Endocrinol, 14, 229
Hirst SJ, 2001, Am J Respir Crit Care Med, 163, A513

Sorted by citations

Items 101–165 of 165

The Role of Interleukin-4 and Interleukin-13 in the Non-Immunologic Aspects of Asthma Pathogenesis
Izuhara, K. (2003) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2003.130 · Cited by 23
IL-4-induced upregulation of adenine nucleotide translocase 3 and its role in Th cell survival from apoptosis
Jang, J.-Y., & Lee, C. (2006) · Cellular Immunology · doi:10.1016/j.cellimm.2006.07.006 · Cited by 24
Melatonin modulates airway smooth muscle cell phenotype by targeting the STAT3/Akt/GSK-3β pathway in experimental asthma
Yu, Q., Yu, X., Zhong, X., Ma, Y., Wu, Y. H., Bian, T., Huang, M., & Zeng, X. (2019) · Cell and Tissue Research · doi:10.1007/s00441-019-03148-x · Cited by 22
Integrative Roles of Pro‐Inflammatory Cytokines on Airway Smooth Muscle Structure and Function in Asthma
Ford, M. L., Reza, M. I., Ruwanpathirana, A., Sathish, V., & Britt, R. D. (2025) · Immunological Reviews · doi:10.1111/imr.70007 · Cited by 27
“IL-4 and IL-13 stimulate human ASM to secrete CC chemokine ligand 11 (CCL11) and CCL24, which are chemokines that recruit eosinophils to the site of inflammation [65, 66].”
Association of eotaxin-2 gene polymorphisms with plasma eotaxin-2 concentration
Min, J.-W., Lee, J.-H., Park, C., Chang, H. S., Rhim, T. Y., Park, H., Jang, A., & Shin, H.-D. (2005) · Journal of Human Genetics · doi:10.1007/s10038-005-0230-3 · Cited by 19
“Eotaxin-1 is mainly produced by epithelial and mesenchymal cells, including fibroblast and smooth muscle in the airway (Ying et al. 1999; Miyamasu et al. 2000; Moore et al. 2002).”
Background
Elastase alters contractility and promotes an inflammatory synthetic phenotype in airway smooth muscle tissues
Lockett, A. D., Wu, Y., & Gunst, S. J. (2017) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00334.2017 · Cited by 19
“7), all of which are characteristic of ASM tissue inflammation (12, 16, 19, 20, 29, 31, 32, 34, 44).”
Background
CCR3
Forsythe, P., & Befus, A. D. (2003) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.f265 · Cited by 19
Focal adhesion kinase (FAK) and mechanical stimulation negatively regulate the transition of airway smooth muscle tissues to a synthetic phenotype
Wu, Y., Huang, Y., & Gunst, S. J. (2016) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00299.2016 · Cited by 18
“We analyzed the effects of mechanical loads on the secretion of eotaxin, an eosinophil chemotactic protein that is synthesized by the smooth muscle in response to stimulation with IL-13, IL-4, and other inflammatory cytokines (5, 21, 29, 34).”
Background
Examining the Role of Type 2 Inflammation in Eosinophilic Esophagitis
Chehade, M., Falk, G. W., Aceves, S. S., Lee, J. K., Mehta, V., Leung, J., Shumel, B. S., Jacob-Nara, J. A., Deniz, Y. M., Rowe, P. J., et al. (2022) · Gastro Hep Advances · doi:10.1016/j.gastha.2022.05.004 · Cited by 19
Basophils as Key Regulators of Allergic Inflammation and Th2-type Immunity
Gibbs, B. F. (2008) · World Allergy Organization Journal · doi:10.1097/wox.0b013e31817a76fb · Cited by 17
Role of Mitogen-Activated Protein Kinases in Peptidoglycan-Induced Expression of Inducible Nitric Oxide Synthase and Nitric Oxide in Mouse Peritoneal Macrophages: Extracellular Signal-Related Kinase, a Negative Regulator
Bhatt, K. H., Sodhi, A., & Chakraborty, R. (2011) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00541-10 · Cited by 17
“This might contribute to our understanding of the mechanism(s) of action of the anti-inflammatory cytokines (IL-13 and IL-4) that activate ERK MAPK in the course of their intracellular signaling (37).”
Background
Interleukin‐4 activates large‐conductance, calcium‐activated potassium (BKCa) channels in human airway smooth muscle cells
Martin, G. E., O'Connell, R. J., Pietrzykowski, A. Z., Treistman, S. N., Ethier, M. F., & Madison, J. M. (2008) · Experimental Physiology · doi:10.1113/expphysiol.2008.042432 · Cited by 17
“…differential effects of these two cytokines have already been well described for this cell type in multiple studies (Hawker et al. 1998; John et al. 1998a,b; Pype et al. 1999; Bamford et al. 2000; Laporte et al. 2001; Madison & Ethier, 2001; Hirst et al. 2002; Moore et al. 2002; Faffe et al. 2006).”
BackgroundMethod
Tenascin-C deficiency in apo E−/− mouse increases eotaxin levels: Implications for atherosclerosis
Wang, L., Shah, P. K., Wang, W., Song, L., Yang, M., & Sharifi, B. G. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.01.039 · Cited by 16
Heparin and structurally related polymers attenuate eotaxin‐1 (CCL11) release from human airway smooth muscle
Kanabar, V., Page, C. P., Simcock, D. E., Karner, C., Mahn, K., O'Connor, B. J., & Hirst, S. J. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.109 · Cited by 16
“A key stimulus eliciting eotaxin-1 release from ASM in vitro is the Th2 (T helper-2) cytokine, interleukin (IL)-13 (Hirst et al., 2002; Moore et al., 2002).”
Background
A Mathematical Modeling Approach to Understanding the Effect of Anti‐Interleukin Therapy on Eosinophils
Karelina, T., Voronova, V., Demin, O. O., Colice, G., & Agoram, B. (2016) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12129 · Cited by 14
“22 EOS apoptosis is inhibited mainly by IL-523 and with less potency by IL-13.”
BackgroundInfluential
Basophils as critical orchestrators of Th2-type immune responses
Gibbs, B. F., Streatfield, C., & Falcone, F. H. (2009) · Expert Review of Clinical Immunology · doi:10.1586/eci.09.47 · Cited by 13
Molecular Mechanisms of Repression of Eotaxin Expression with Fluticasone Propionate in Airway Epithelial Cells
Matsukura, S., Kokubu, F., Kurokawa, M., Kawaguchi, M., Kuga, H., Ieki, K., Odaka, M., Suzuki, S., Watanabe, S., Takeuchi, H. T., et al. (2004) · International Archives of Allergy and Immunology · doi:10.1159/000077787 · Cited by 13
The effects of neutralizing anti-murine interleukin-17A monoclonal antibody on ozone-induced inflammation and glucocorticoids insensitivity in a murine model of asthma
Zhang, Y., Li, X., He, M., Zhang, G., Bao, W., Fei, X., Zhang, X., Zhang, M., & Zhang, P. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108786 · Cited by 12
Targeting eosinophils in chronic respiratory diseases using nanotechnology-based drug delivery
Sharma, P., Dhanjal, D. S., Chopra, C., Tambuwala, M. M., Sohal, S. S., van der Spek, P. J., SHARMA, H. S., & Satija, S. (2022) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2022.110050 · Cited by 12
Regulation of IL-17A responses in human airway smooth muscle cells by Oncostatin M
Kwofie, K., Scott, M., Rodrigues, R., Guerette, J., Radford, K., Nair, P. K., & Richards, C. D. (2015) · Respiratory Research · doi:10.1186/s12931-014-0164-4 · Cited by 12
“HASMC can respond directly to Th2 cytokines [14,15] and with synergy in response to Th2 cytokine and IL-1 combinations [16].”
Background
Transcriptional Regulation of Inflammatory Genes Associated with Severe Asthma
Clifford, R. L., Coward, W. R., Knox, A. J., & John, A. E. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211795429000 · Cited by 11
“Induction of CCL11 by the Th2 cytokines, IL-4 and IL-13, is mediated via STAT6 activation whereas TNF -induced transcription is dependent on NF B but independent of STAT-6 [99, 100].”
Background
Regulation of Eosinophil Recruitment and Allergic Airway Inflammation by Tropomyosin Receptor Kinase A
Dileepan, M., Ge, X. N., Baştan, İ., Greenberg, Y. G., Liang, Y., Sriramarao, P., & Rao, S. P. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1900786 · Cited by 11
“Studies have shown that activation of TrkA signaling promotes human airway smooth muscle cell proliferation (68) and smooth muscle cells can be a source of eotaxins during asthma (69).”
Background
IL‐4 inhibits calcium transients in bovine trachealis cells by a ryanodine receptor dependent mechanism
Ethier, M. F., & Madison, J. M. (2005) · The FASEB Journal · doi:10.1096/fj.05-4031fje · Cited by 10
The COX-2 inhibitor SC-236 exerts anti-inflammatory effects by suppressing phosphorylation of ERK in a murine model
Kim, S., Jeong, H., Moon, P., Myung, N., Kim, M.-C., Kang, T., Lee, K., Park, R., So, H., Kim, E.-C., et al. (2007) · Life Sciences · doi:10.1016/j.lfs.2007.06.027 · Cited by 10
Th2 cytokine signaling through IL-4Rα increases eotaxin-3 secretion and tension in human esophageal smooth muscle
Nelson, M. R., Zhang, X., Podgaetz, E., Wang, X., Zhang, Q., Pan, Z., Spechler, S. J., & Souza, R. F. (2023) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00155.2023 · Cited by 9
Eosinophilic granulomatosis with polyangiitis: current status and future perspectives
Kamide, Y., & Taniguchi, M. (2025) · Respiratory Investigation · doi:10.1016/j.resinv.2025.04.018 · Cited by 9
An update on bronchopulmonary dysplasia: Is there a relationship to the development of childhood asthma?
Smith, J. (2003) · Medical Hypotheses · doi:10.1016/s0306-9877(03)00204-4 · Cited by 9
From Beneath the Skin to the Airway Wall: Understanding the Pathological Role of Adipose Tissue in Comorbid Asthma‐Obesity
Wang, C., Noble, P. B., Elliot, J., James, A. L., & Wang, K. C. W. (2023) · Comprehensive physiology · doi:10.1002/cphy.c220011 · Cited by 8
Lung Function Decline in Asthma: Mechanisms, Risk Factors, and Clinical Implications for Personalized Management
Portacci, A., Pelaia, C., Bagnasco, D., Paoletti, G., Nolasco, S., & de Paulis, A. (2026) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2026.01.043 · Cited by 10
The proprotein convertase furin inhibits IL-13-induced inflammation in airway smooth muscle by regulating integrin-associated signaling complexes
Wu, Y., Huang, Y., Zhang, W., & Gunst, S. J. (2021) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00618.2020 · Cited by 7
Airway smooth muscle: new targets for asthma pharmacotherapy
Lazaar, A. L. (2002) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.6.4.447 · Cited by 7
“Eotaxin is present in vivo in smooth muscle in asthmatics and is released by cultured ASM upon stimulation with TNF-α , IL-1β, IL-4 or IL-13 [38-40].”
BackgroundInfluential
Effectiveness of Switching From Upadacitinib to Tralokinumab in Patients With Moderate-to-Severe Atopic Dermatitis: A Real-World Clinical Practice
Hagino, T., Saeki, H., Fujimoto, E., & Kanda, N. (2025) · Annals of Dermatology · doi:10.5021/ad.24.127 · Cited by 6
“Similarly, previous studies showed that treatment with anti-IL-13 antibodies, such as lebrikizumab and tralokinumab, or the IL-4R α antibody dupilumab, prompted a transient rise in TEC among patients with AD 36-40 CCL11 and CCL24 within fibroblasts, monocytes, or smooth muscle cells 41,42 .”
The 21st century renaissance of the basophil? Current insights into its role in allergic responses and innate immunity
Falcone, F. H., Zillikens, D., & Gibbs, B. F. (2006) · Experimental Dermatology · doi:10.1111/j.0906-6705.2006.00477.x · Cited by 6
Markers of tyrosine kinase activity in eosinophilic esophagitis: a pilot study of the FIP1L1-PDGFRα fusion gene, pERK 1/2, and pSTAT5
Dellon, E. S., Bower, J. J., Keku, T. O., Chen, X., Miller, C. R., Woosley, J. T., Orlando, R. C., & Shaheen, N. J. (2011) · Diseases of the Esophagus · doi:10.1111/j.1442-2050.2011.01230.x · Cited by 6
TP receptor-mediated release of eosinophil chemotactic activity from human bronchial smooth muscle cells
Suzuki, Y., Asano, K., Niimi, K., Miyata, J., Shiraishi, Y., Fukunaga, K., Shiomi, T., Nakajima, T., Oguma, T., Sayama, K., et al. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.09.044 · Cited by 6
“…IL-4 itself induces CCL11 synthesis in a MAP kinase-dependent manner; blockade of MAP kinases either with U0126 or SB202190 suppressed the release of CCL11 from IL-4-stimulated BSMC (our unpublished observations), as other researchers previously reported (Hirst et al., 2002; Moore et al., 2002).”
Result
Fingolimod attenuates ovalbumin‐induced airway inflammation via inhibiting MAPK/ERK signaling in mice
Makled, M. N., & El‐Sheakh, A. R. (2022) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.23266 · Cited by 5
Cell-Specific Contribution of IL-4 Receptor α Signaling Shapes the Overall Manifestation of Allergic Airway Disease
Choudhary, I., Lamichhane, R., Singamsetty, D., Vo, T., Brombacher, F., Patial, S., & Saini, Y. (2024) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2024-0208oc · Cited by 4
Development of an in vitro potency bioassay for therapeutic IL-13 antagonists: The A-549 cell bioassay
Miller, R., Sadhukhan, R., & Wu, C. (2008) · Journal of Immunological Methods · doi:10.1016/j.jim.2008.02.009 · Cited by 5
Small animals models for drug discovery
Martin, J. G., & Novali, M. (2011) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2011.05.002 · Cited by 5
T cell and airway smooth muscle interaction: a key driver of asthmatic airway inflammation and remodeling
Zhou, M., Sun, R., Jang, J. H., & Martin, J. G. (2024) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00121.2024 · Cited by 4
Fibroblast growth factor‐2 and interleukin‐4 synergistically induce eotaxin‐1 expression in adipose tissue‐derived stromal cells
Hattori, H., & Ishihara, M. (2020) · Cell Biology International · doi:10.1002/cbin.11309 · Cited by 4
“IL‐13 and IL‐4 cause eotaxin release in human airway smooth muscle cells, and this mechanism involves ERK activation (Moore et al., 2002).”
Influential
Involvement of ERK and Oxidative Stress in Airway Exposure to Cadmium Chloride Aggravates Airway Inflammation in Ovalbumin-Induced Asthmatic Mice
Wu, C., Hu, X., Jiang, Y., Tang, J., Ge, H., Deng, S., Li, X., & Feng, J. (2024) · Toxics · doi:10.3390/toxics12040235 · Cited by 4
Airway Smooth Muscle and Asthma
Gunst, S. J. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-381510-1.00104-6 · Cited by 4
Comparable Function of γ-Tocopherols in Asthma Remission by Affecting Eotaxin and IL-4
Wu, Y., Xue, Z., Zhang, L.-L., Gao, N.-M., Du, X.-M., Zhang, X., Zhang, Z., & Zhang, Z.-G. (2016) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/41191 · Cited by 4
IL-13 R110Q, a Naturally Occurring IL-13 Polymorphism, Confers Enhanced Functional Activity in Cultured Human Bronchial Smooth Muscle Cells
He, Y., Hua, L., Bao, Y., Liu, Q.-H., Chu, Y., & Fang, D. (2013) · Allergy Asthma and Immunology Research · doi:10.4168/aair.2013.5.6.377 · Cited by 3
“In vivo animal models and in vitro cell culture studies also support a role of IL13 in eotaxin release and eosinophil recruitment.(14,23) The modulation of FcεRI expression in ASM is a potentially important mechanism in asthma,(13,41) and IgE has been shown to upregulate FcεRI expression in human mast cells and ASM ce…”
Background
Role of ROCK 2 in CD 4 + cells in allergic airways responses in mice
Kasahara, D. I., Mathews, J. A., Ninin, F. M. C., Wurmbrand, A. P., Liao, J. K., & Shore, S. A. (2016) · Clinical & Experimental Allergy · doi:10.1111/cea.12866 · Cited by 3
Self-citation
Adeno-Associated Viral Vector-Delivered Pannexin-1 Mimetic Peptide Alleviates Airway Inflammation in an Allergen-Sensitized Mouse Model
Huang, Y.-A., Chen, J., Chiang, P., Chen, L., & Kuo, M. (2023) · Human Gene Therapy · doi:10.1089/hum.2023.078 · Cited by 3
“Th2 cytokine, especially IL-5, leads to the development of eosinophils from the bone marrow, 3 and IL-4 and IL-13 trigger the expression of eosinophil chemokines from structural cells, 40 causing eosinophilic inﬁltration.”
Blockade of ankyrin repeat-rich membrane spanning protein modulates extracellular signal-regulated kinase expression and inhibits allergic inflammation in ovalbumin-sensitized mice
Ni, X., Li, X., TAO, S., Xu, M., Ma, H., & Wang, X. (2013) · Biomedical Reports · doi:10.3892/br.2013.120 · Cited by 3
“These effects are regulated to some extent by MAPK activation (34).”
Evaluation of Ginkgo biloba as Alternative Medicine on Ova-Induced Eotaxin and Eosinophilia in Asthmatic Lung
Tabl, G. A., & Elwy, A. E.-H. M. (2013) · Cited by 2
IL-13 and its Signal Pathway: Promising Targets in the Development of a Therapeutic Agent for Bronchial Asthma
Izuhara, K., Arima, K., Kanaji, S., Kanaji, T., & Ohta, S. (2007) · Current Signal Transduction Therapy · doi:10.2174/157436207779317128 · Cited by 2
“Furthermore, IL-13 induces production of eotaxin [104, 105] and enhances contractility [106, 107] in bronchial smooth muscle cells.”
Background
The role of innate lymphoid cells in the heart and cardiac inflammation
Choi, H. S., Hou, X., Bracamonte‐Baran, W., Diny, N. L., Talor, M. V., & Čiháková, D. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.200.supp.42.22 · Cited by 2
Homeostatic glucocorticoid signaling in airway smooth muscle: A roadmap to asthma pathogenesis
GRUNSTEIN, M. M. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1077389 · Cited by 1
Airway Smooth Muscle Dysfunction in Asthma
Sukkar, M. B., & Chung, K. F. (2009) · Springer eBooks · doi:10.1007/978-4-431-88315-9_23
Effects of IL-33 on the interaction between HMC-1 cells and human airway smooth muscle cells
Jones, R. (2009) · Enlighten: Theses (The University of Glasgow)
CYTOKINE MODULATION OF PROGENITOR CELL MIGRATION
Punia, N. (2011) · MacSphere (McMaster University) · doi:10.71548/25096
Relationship of serum IL-13 and eotaxin level with airway hyperresponsiveness in children with asthma
Park, E. Y., Shim, J. Y., Yoo, M. H., Kim, D. S., Shim, J. W., Jung, H. L., & Park, M. S. (2006) · Korean Journal of Pediatrics · doi:10.3345/kjp.2006.49.8.889
PAK1's regulation of eosinophil migration and implications for asthmatic inflammation
Mwanthi, M. (2013) · IUScholarWorks (Indiana University) · doi:10.7912/c2/1720
The Receptor For Advanced Glycation End-Products Is A Central Mediator Of Asthma Pathogenesis
Milutinovic, P. S., Alcorn, J. F., Englert, J. M., Crum, L. T., & Oury, T. D. (2012) · doi:10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a4294
Cellular and Molecular Basis of Asthma
Khan, M. M. (2016) · Springer eBooks · doi:10.1007/978-3-319-30273-7_7
TGF-β1-induced Chloride Channel Activity and Migration of Human Eosinophils
Moore, B. T. (2009) · Creighton Digital Repository (CDR)
Cellular interactions of airway smooth muscle and human lung mast cells
Woodman, L. (2009) · OpenGrey (Institut de l'Information Scientifique et Technique)
IL-13R130Q modulates human airway smooth muscle cell phenotype to contribute to severe asthmaPreprint
He, Y., Pan, Q., Li, L., Liu, Q., Bao, Y., & Zhang, J. (2022) · Research Square · doi:10.21203/rs.3.rs-1741583/v1
Research Progress on the Relationship between Bronchopulmonary Dysplasia in Children and Chronic Lung Diseases in Adulthood
伍, 倩. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.1441164
Omalizumab is ineffective in regulating proasthmatic serum cytokine and chemokine levels in nonresponders with high BMI
Yang, A., Gu, C., Upchurch, K., Caffiers, A., Millard, M., Baert, L., Joo, H., & Oh, S. (2025) · Journal of Allergy and Clinical Immunology Global · doi:10.1016/j.jacig.2025.100462
“Disclosure of potential conﬂict of interest: The authors declare that they have no relevant conﬂicts of interest.”
Inflammatory Mediators in the Airway: A Structural Cells’ Perspective
Tesch, J., Pandey, S., Adhikari, R., & Sathish, V. (2025) · Springer eBooks · doi:10.1007/978-3-031-55254-0_10-1

Authors: Moore, P. E., Church, T. L., Chism, D. D., Panettieri, R. A., & Shore, S. A.
Affiliations: Harvard University (US)
University of Pennsylvania (US)
ORCID: Moore, Paul E.
Chism, David D.
Panettieri, Reynold A.
Shore, Stephanie A.
Venue: American Journal of Physiology-Lung Cellular and Molecular Physiology
Publisher: American Physiological Society
Published: 2002-04-01
Volume: 282
Issue: 4
Pages: L847-L853
ISSN: 1040-0605 (ISSN-L)
1522-1504
DOI: 10.1152/ajplung.00245.2001
OpenAlex: W2150773437
Cited by: 166
References: 49
Citations by year: 2026: 1 · 2025: 6 · 2024: 4 · 2023: 7 · 2022: 5 · 2021: 3 · 2020: 2 · 2019: 6 · 2018: 6 · 2017: 2 · 2016: 5 · 2015: 4 · 2014: 3 · 2013: 9 · 2012: 5
FWCI: 8.61
Type: journal article
Language: en
Open access: closed
Locations: American Journal of Physiology-Lung Cellular and Molecular Physiology (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (5p50hl056383-06)
National Heart, Lung, and Blood Institute (HL04395, P01HL033009, HL-33009, HL 56383, K08HL004395)
Topics: Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
Health Sciences › Medicine › Immunology and Allergy › Allergic Rhinitis and Sensitization
Keywords: IL-13, IL-4, eotaxin, CCL17, airway smooth muscle cells, ERK activation, MAPK signaling, TNF-α, chemokine secretion, eosinophil recruitment, asthma, U0126, PD98059
MeSH terms: Antineoplastic Agents, Asthma, Butadienes, Cells, Cultured, Enzyme Inhibitors, Flavonoids, Humans, Muscle, Smooth, Nitriles, RNA, Messenger, Trachea, Tumor Necrosis Factor-alpha, Interleukin-4, Gene Expression, Interleukin-13, Chemokines, CC, Mitogen-Activated Protein Kinases, Chemokine CCL11

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

IL-13 and IL-4 cause eotaxin release in human airway smooth muscle cells: a role for ERK

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks